Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Butzkueven

Showing results (241-250 of 390) with videos related to

Pageof 39
Sort By:
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Plos Genetics|March 19, 2016
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 StatusMichele D Binder, Andrew D Fox, Daniel Merlo, et al.
International Journal of Molecular Sciences|August 26, 2023
DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and MonocytesAlexandre Xavier, Vicki E Maltby, Ewoud Ewing, et al.
Journal of Neurology|April 1, 2026
Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosisMichael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Neurology|July 1, 2021
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple SclerosisIzanne Roos, Emmanuelle Leray, Romain Casey, et al.
NPJ Digital Medicine|October 19, 2023
A real-world clinical validation for AI-based MRI monitoring in multiple sclerosisMichael Barnett, Dongang Wang, Heidi Beadnall, et al.
Plos One|November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisJudith Field, Sharon R Browning, Laura J Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 27, 2024
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBaseTim Spelman, Sara Eichau, Raed Alroughani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 2024
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Pageof 39

Showing results (241-250 of 390) with videos related to

Sort By:
Pageof 39
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Plos Genetics|March 19, 2016
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 StatusMichele D Binder, Andrew D Fox, Daniel Merlo, et al.
International Journal of Molecular Sciences|August 26, 2023
DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and MonocytesAlexandre Xavier, Vicki E Maltby, Ewoud Ewing, et al.
Journal of Neurology|April 1, 2026
Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosisMichael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Neurology|July 1, 2021
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple SclerosisIzanne Roos, Emmanuelle Leray, Romain Casey, et al.
NPJ Digital Medicine|October 19, 2023
A real-world clinical validation for AI-based MRI monitoring in multiple sclerosisMichael Barnett, Dongang Wang, Heidi Beadnall, et al.
Plos One|November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisJudith Field, Sharon R Browning, Laura J Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 27, 2024
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBaseTim Spelman, Sara Eichau, Raed Alroughani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 2024
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Pageof 39